$SFBS Cashflow Statement | Understand Stock

$SFBS

$40.68 -$0.41 (1.0%) Close

$SFBS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
OPERATING ACTIVITIES
Net income
Adjustments to reconcile net income to net cash provided by operating activities
Deferred tax expense (benefit)
Provision for credit losses
Depreciation
Accretion on acquired loans
Amortization of core deposit intangible
Amortization of investments in tax credit partnerships
Net amortization (accretion) of debt securities
Decrease (increase) in accrued interest and dividends receivable
Stock-based compensation expense
Increase in accrued interest and dividends payable
Proceeds from sale of mortgage loans held for sale
Originations of mortgage loans held for sale
Gain on sale of mortgage loans held for sale
Loss on sale of securities available for sale
Net (gain) loss on sale of other real estate owned and repossessed assets
Write down of other real estate owned and repossessed assets
Operating losses of tax credit partnerships
Increase in cash surrender value of life insurance contracts
Net change in other assets, liabilities, and other operating activities
Net cash provided by operating activities
INVESTMENT ACTIVITIES
Purchases of debt securities available-for-sale
Proceeds from maturities, calls and paydowns of debt securities available-for-sale
Proceeds from sale of debt securities available-for-sale
Purchases of debt securities held-to-maturity
Proceeds from maturities, calls and paydowns of debt securities held-to-maturity
Purchases of restricted equity securities
Proceeds from sale of restricted equity securities
Investment in tax credit partnerships and SBIC
Return of capital from tax credit partnerships and SBIC
Net increase in loans
Purchases of premises and equipment
Purchase of bank owned life insurance contracts
Proceeds from death benefit of bank owned life insurance contracts
Proceeds from sale of other real estate owned and repossessed assets
Expenditures for other real estate owned
Net cash used in investing activities
FINANCING ACTIVITIES
Net increase (decrease) in non-interest-bearing deposits
Net increase in interest-bearing deposits
Net (decrease) increase in federal funds purchased
Proceeds from issuance of 4% Subordinated Notes due October 21, 2030, net of issuance cost
Repayment of 5% Subordinated Notes due July 15, 2025
FHLB advances
Repayment of FHLB advances
Redemption of other borrowings
Proceeds from exercise of stock options
Taxes paid in net settlement of tax obligation upon exercise of stock options
Dividends paid on common stock
Dividends paid on preferred stock
Net cash provided by financing activities
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

SUPPLEMENTAL DISCLOSURE
Interest
Income taxes
Income tax refund
NONCASH TRANSACTIONS
Other real estate acquired in settlement of loans
Internally financed sale of other real estate owned
Debt securities available for sale transferred to held to maturity
Dividends on nonvested restricted stock reclassified as compensation expense
Dividends declared but not paid

Comments